#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arrhythmia Stargardt's disease Superficial vein thrombosis Parkinson's disease Philadelphia chromosome positive Friedreich's ataxia Henoch-Schonlein purpura Proteus syndrome Diffuse large B-cell lymphoma refractory Haemophilia A without inhibitors Neonatal asphyxia Oesophageal achalasia Anti-glomerular basement membrane disease Lymphangioma Cardiac amyloidosis More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Trials in Disease Hereditary optic atrophy – Life with Disease Hyperoxaluria – Trials in Disease Lymphatic malformation – Treatment Waldenstrom’s macroglobulinaemia refractory Optic glioma – Basic Information Hereditary neuropathic amyloidosis – Life with Disease Mastocytosis – Basic Information Sarcoma – Diagnostics Leiomyosarcoma metastatic – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benserazide Hydrochloride Mk-2060 Rbd5044 Sodium Asp1570 Ribonucleic Acid K30 Azd8630 Concizumab Ep0031 MRNA-1345 Metoprolol Succinate Eletriptan Bdc-1001 Interferon Beta-1B POTASSIUM CLAVULANATE 534 Mva-209-Fsp-B4 Asundexian Apg777 NALDEMEDINE Fluorouracil Sodium More therapies…

    Learn about Your Condition

    Tendon rupture Hyperinsulinism Postoperative delirium Non-small cell lung cancer Periodontitis Peripheral artery restenosis Neuropathy peripheral Hypochromic anaemia Death neonatal Pyrexia Acute myocardial infarction Vulvar dysplasia Nervous system disorder Acute myeloid leukaemia Liposarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Stargardt’s disease

  • A study to evaluate the safety and tolerability of tinlarebant in patients with Stargardt disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tinlarebant
    Belgium France The Netherlands

  • Evaluation of SB-007 Safety and Efficacy in Patients with Stargardt Disease Type 1 (STGD1) Caused by ABCA4 Gene Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, C-REGION
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, N-REGION
    Belgium Germany

  • A study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Belgium Italy The Netherlands Norway

  • Study on the Long-Term Safety of SAR422459 for Patients with Stargardt’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Stargardt’s disease
    Investigated Drugs:
    • Lentiviral Vector Containing The Human Abca4 Gene
    France

  • Study on Tinlarebant for Treating Stargardt Disease in Adolescents

    Not recruiting

    3 1
    Investigated Drugs:
    • Tinlarebant
    Belgium France Germany The Netherlands

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!